T1	Participants 37 96	patients with chronic myeloid leukemia in the chronic phase
T2	Participants 233 300	patients with chronic myeloid leukemia treated by allogeneic marrow
T3	Participants 317 343	while in the chronic phase
T4	Participants 566 586	Fifty-seven patients
T5	Participants 1332 1392	patients receiving the higher dose of total body irradiation
